DEA’s Broader Marijuana Schedule III Hearing Opens June 29 With Seven Outside Participants
The federal hearing will decide whether marijuana beyond already-rescheduled state medical products should move to Schedule III, fixing the timetable and the voices that will shape the record.
Read more
